BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• MorphoSys Presents Interim Results from M-PLACE Study with Felzartamab during American Society of Nephrology Annual Meeting

  MorphoSys AG presented interim results from the M-PLACE study with felzartamab at the 2021 Annual Meeting of the American Society of Nephrology (ASN) on November 4-7.

  November 4, 2021

   · 

  9 min read
• FDA

  FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit

  ReWalk Robotics, Ltd. today announced its ReBoot device has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA).

  November 4, 2021

   · 

  7 min read
• Business

  Tabula Rasa HealthCare Reports Third Quarter 2021 Results

  Tabula Rasa HealthCare, Inc. (“TRHC”) (Nasdaq: TRHC), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the third quarter ended September 30, 2021.

  November 4, 2021

   · 

  19 min read
• Genetown

  2seventy bio to Present Data from its Portfolio of Oncology Cell Therapies at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

  2seventy bio to Present Data from its Portfolio of Oncology Cell Therapies at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition

  November 4, 2021

   · 

  22 min read
• Galapagos reports commercial and operational progress at Q3 financial results

  Galapagos NV is pleased to report on itscommercial launch of filgotinib in Europe.The company is moving forward with its revised R&D strategy and operational restructuring announced in May, resulting in a downward adjustment of thecash burn by €50 million.

  November 4, 2021

   · 

  17 min read
• Business

  Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021

  Cellectis S.A. today announced results for the three-month and nine-month periods ending September 30, 2021.

  November 4, 2021

   · 

  33 min read
• Business

  Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA® Electronic Health Records System

  Castle Biosciences’ Full DecisionDx® Portfolio of Dermatologic Tests to Be Interfaced with EMA ® Electronic Health Records System

  November 4, 2021

   · 

  4 min read
• Biotech Beach

  Eledon Pharmaceuticals CEO David-Alexandre C. Gros, M.D., to Present at CareDx Virtual Transplant Innovation Day during ASN Kidney Week 2021

  Eledon Pharmaceuticals, Inc. announced today that David-Alexandre C. Gros, M.D., Chief Executive Officer of Eledon, will deliver a presentation at the CareDx virtual Transplant Innovation Day

  November 4, 2021

   · 

  4 min read
• Policy

  US Food and Drug Administration Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for Patients with Critical COVID-19 with Respiratory Failure

  NRx Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that the US Food and Drug Administration has declined to issue an Emergency Use Authorization for ZYESAMI®.

  November 4, 2021

   · 

  5 min read
• Business

  Extendicare Announces 2021 Third Quarter Results

  Extendicare Inc. reported results for the three and nine months ended September 30, 2021.

  November 4, 2021

   · 

  20 min read